We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to HCA (HCA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Read MoreHide Full Article
Wall Street analysts expect HCA Healthcare (HCA - Free Report) to post quarterly earnings of $6.75 per share in its upcoming report, which indicates a year-over-year decline of 3%. Revenues are expected to be $19.38 billion, up 1.1% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 1.2% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific HCA metrics that are routinely monitored and predicted by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenues- Other' will likely reach $1.03 billion. The estimate indicates a change of +60.4% from the prior-year quarter.
It is projected by analysts that the 'Revenues- Medicare' will reach $2.93 billion. The estimate indicates a year-over-year change of +7.6%.
According to the collective judgment of analysts, 'Revenues- Managed Medicare' should come in at $3.20 billion. The estimate indicates a change of -3.1% from the prior-year quarter.
Based on the collective assessment of analysts, 'Revenues- International (Managed Care & Insurers)' should arrive at $464.46 million. The estimate indicates a change of -4% from the prior-year quarter.
The average prediction of analysts places 'Revenue per Equivalent Admission' at $18269.87 . The estimate compares to the year-ago value of $18446.00 .
Analysts expect 'Equivalent Admissions' to come in at 1.06 billion. The estimate compares to the year-ago value of 1.04 billion.
The consensus estimate for 'Admissions' stands at 587.13 million. Compared to the current estimate, the company reported 577.80 million in the same quarter of the previous year.
Analysts predict that the 'Patient Days' will reach 2688 days. The estimate is in contrast to the year-ago figure of 2693 days.
The consensus among analysts is that 'Average Length of Stay' will reach 5 . Compared to the current estimate, the company reported 5 in the same quarter of the previous year.
Analysts forecast 'Number of hospitals' to reach 190 . The estimate is in contrast to the year-ago figure of 191 .
Analysts' assessment points toward 'Inpatient Revenue per Admission' reaching $20762.76 . Compared to the current estimate, the company reported $19908.00 in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Equivalent Patient Days' of 4.84 million. Compared to the present estimate, the company reported 4.84 million in the same quarter last year.
Over the past month, HCA shares have recorded returns of +5.3% versus the Zacks S&P 500 composite's no change. Based on its Zacks Rank #3 (Hold), HCA will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Countdown to HCA (HCA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Wall Street analysts expect HCA Healthcare (HCA - Free Report) to post quarterly earnings of $6.75 per share in its upcoming report, which indicates a year-over-year decline of 3%. Revenues are expected to be $19.38 billion, up 1.1% from the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 1.2% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
Given this perspective, it's time to examine the average forecasts of specific HCA metrics that are routinely monitored and predicted by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenues- Other' will likely reach $1.03 billion. The estimate indicates a change of +60.4% from the prior-year quarter.
It is projected by analysts that the 'Revenues- Medicare' will reach $2.93 billion. The estimate indicates a year-over-year change of +7.6%.
According to the collective judgment of analysts, 'Revenues- Managed Medicare' should come in at $3.20 billion. The estimate indicates a change of -3.1% from the prior-year quarter.
Based on the collective assessment of analysts, 'Revenues- International (Managed Care & Insurers)' should arrive at $464.46 million. The estimate indicates a change of -4% from the prior-year quarter.
The average prediction of analysts places 'Revenue per Equivalent Admission' at $18269.87 . The estimate compares to the year-ago value of $18446.00 .
Analysts expect 'Equivalent Admissions' to come in at 1.06 billion. The estimate compares to the year-ago value of 1.04 billion.
The consensus estimate for 'Admissions' stands at 587.13 million. Compared to the current estimate, the company reported 577.80 million in the same quarter of the previous year.
Analysts predict that the 'Patient Days' will reach 2688 days. The estimate is in contrast to the year-ago figure of 2693 days.
The consensus among analysts is that 'Average Length of Stay' will reach 5 . Compared to the current estimate, the company reported 5 in the same quarter of the previous year.
Analysts forecast 'Number of hospitals' to reach 190 . The estimate is in contrast to the year-ago figure of 191 .
Analysts' assessment points toward 'Inpatient Revenue per Admission' reaching $20762.76 . Compared to the current estimate, the company reported $19908.00 in the same quarter of the previous year.
The collective assessment of analysts points to an estimated 'Equivalent Patient Days' of 4.84 million. Compared to the present estimate, the company reported 4.84 million in the same quarter last year.
View all Key Company Metrics for HCA here>>>Over the past month, HCA shares have recorded returns of +5.3% versus the Zacks S&P 500 composite's no change. Based on its Zacks Rank #3 (Hold), HCA will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .